Latest News
-

Mapping the neighborhood: huntingtin's new protein partners
⏱️ 7 min read
Study of huntingtin protein's 'neighbors' reveals dozens of new drug development targets
-

Does the HD mutation affect children's growth?
⏱️ 6 min read
A small study suggests kids with the HD mutation but no symptoms have subtle differences in growth. What does it mean
-

'Induced' stem cells make exciting advances
⏱️ 8 min read
Stem cells from HD patients: becoming important tools for researchers – and now correcting the HD mutation in the lab
-

ASO gene silencing reaches further, lasts longer
⏱️ 7 min read
Silencing the Huntingtin gene using ASO drugs reaches further, lasts longer and is safe. Human trial soon?
-

Phosphodiesterase inhibitors: new HD drugs entering trials soon
⏱️ 6 min read
CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.
-

Interview: CHDI's scientific team
⏱️ 8 min read
HDBuzz interviews the top scientists from CHDI, the largest funder of Huntington's disease research in the world.
-

Exercise increases cellular recycling
⏱️ 5 min read
Exercise boosts cellular recycling in mice. Could this be why exercise is also good for HD – or even help develop dru
-

The HDBuzz Prize for young science writers
⏱️ 3 min read
Announcing the HDBuzz Prize for young science writers!
-

What's the connection between Huntington's Disease and cancer?
⏱️ 6 min read
HD patients are less likely to get cancer, according to a study from Sweden – what does this mean?
-

Closing the care gap: new guidelines for HD care
⏱️ 6 min read
Closing the care gap: new guidelines to help every Huntington's disease patient get great care
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
